Christopher Ellis - 28 Jun 2022 Form 4 Insider Report for Vaccitech plc (BRNS)

Role
Chief Operating Officer
Signature
/s/ William Enright, Attorney-in-Fact
Issuer symbol
BRNS
Transactions as of
28 Jun 2022
Net transactions value
-$30
Form type
4
Filing time
15 Jul 2022, 16:06:08 UTC
Previous filing
11 Feb 2022
Next filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VACC Ordinary Shares Options Exercise $0.002 +5 +6.7% $0.000400* 80 28 Jun 2022 Direct F1
transaction VACC Ordinary Shares Sale $30 -5 -6.2% $6.00 75 28 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VACC Share Option (Right to Buy) Options Exercise $0 -5 -0.01% $0.000000 50,980 28 Jun 2022 Ordinary Shares 5 $0.000400 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 This option is fully vested and exercisable as of the date hereof. The exercise price of this option is GBP 0.000324 per share and has been converted from pounds sterling to U.S. dollars using an average exchange rate of $1.3269 to GBP 1.00 on December 31, 2019.